Features of hypoxic resistance in children with bronchial asthma who have undergone a new coronavirus infection

Cover Page

Abstract

Aim. To study the characteristics of resistance/sensitivity to normobaric hypoxia in 50 children with bronchial asthma (BA) from 9 to 12 years old, 24 of them after a previous coronavirus infection СOVID-19.

Materials and methods. A normobaric hypoxic test (HT) was carried out by creating hypoxemia (threshold level SpO2 80%) during mask inhalation of a gas mixture with 10–11% O2 by a child using a ReOxy Cardio apparatus (Ai Mediq S.A., Luxembourg). The data obtained were compared with the results in a group of healthy children the same age.

Results. It was found that the integral level of hypoxic resistance of children with BA was generally lower in comparison with the group of healthy children, which was manifested in lower values of the hypoxic index (3.1±1.4, in the group of healthy children – 4.9±2.8, p=0.005), a significantly increased level of tachycardia and a hypotonic response to dosed hypoxia.

Conclusion. When typing reactions to HT, it was found that in children with BA, the type of low resistance to hypoxia is more common (to a greater extent in children with BA after a coronavirus infection), which confirms the need to involve such children in comprehensive rehabilitation programs.

Full Text

Restricted Access

About the authors

Oleg S. Glazachev

Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: glazachev@mail.ru
ORCID iD: 0000-0001-9960-6608

D. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)

Russian Federation, Moscow

Natalia A. Geppe

Sechenov First Moscow State Medical University (Sechenov University)

Email: geppe@mail.ru
ORCID iD: 0000-0003-0547-3686

D. Sci. (Med.), Prof., Sechenov First Moscow State Medical University (Sechenov University)

Russian Federation, Moscow

Iurii S. Timofeev

Sechenov First Moscow State Medical University (Sechenov University)

Email: ust.0747@gmail.com
ORCID iD: 0000-0002-3665-5127

Graduate Student, Sechenov First Moscow State Medical University (Sechenov University)

Russian Federation, Moscow

Marina D. Shakhnazarova

Sechenov First Moscow State Medical University (Sechenov University)

Email: marinashakh@mail.ru
ORCID iD: 0000-0003-3512-5455

Cand. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)

Russian Federation, Moscow

Natalia G. Kolosova

Sechenov First Moscow State Medical University (Sechenov University)

Email: kolosovan@mail.ru
ORCID iD: 0000-0001-5071-9302

Cand. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)

Russian Federation, Moscow

Vlada G. Samartseva

Sechenov First Moscow State Medical University (Sechenov University)

Email: glazachev@mail.ru
ORCID iD: 0000-0003-1266-312X

Graduate Student, Sechenov First Moscow State Medical University (Sechenov University)

Russian Federation, Moscow

Elena N. Dudnik

Sechenov First Moscow State Medical University (Sechenov University)

Email: elenad.72@list.ru
ORCID iD: 0000-0003-4571-1781

Cand. Sci. (Biol.), Sechenov First Moscow State Medical University (Sechenov University)

Russian Federation, Moscow

Aleksandr B. Malakhov

Sechenov First Moscow State Medical University (Sechenov University)

Email: alexis4591m@mail.ru
ORCID iD: 0000-0002-2686-8284

D. Sci. (Med.), Prof., Sechenov First Moscow State Medical University

Russian Federation, Moscow

Elena V. Frolkova

Sechenov First Moscow State Medical University (Sechenov University)

Email: glazachev@mail.ru

Cand. Sci. (Med.), Sechenov First Moscow State Medical University

Russian Federation, Moscow

Irina I. Kalinovskaya

Children’s Bronchopulmonary Sanatorium №15

Email: super_irina@bk.ru
ORCID iD: 0000-0002-3327-4687

Cand. Sci. (Med.), Children’s Bronchopulmonary Sanatorium №15

Russian Federation, Moscow

References

  1. The Global Asthma Report 2018. Available at: http://globalasthmareport.org Accessed: 2018.
  2. Gina: interim guidance about covid-19 and asthma. Available at: https://ginasthma.org Accessed: 20.12.2020.
  3. Николаева А.Г. Использование адаптации к гипоксии в медицине и спорте. Монография. Витебск: ВГМУ, 2015 [Nikolaeva AG. The use of adaptation to hypoxia in medicine and sports. Monograph.Vitebsk: VSMU, 2015 (in Russian)].
  4. Агарджанян Н.А., Миррахимов Н.А. Горы и резистентность организма. М.: Наука, 1989 [Agardzhanian NA, Mirrakhimov NA. Mountains and body resistance. Moscow: Nauka, 1989 (in Russian)].
  5. Якушенко М.И. Особенности адаптации детей к горному климату и эффективность горноклиматического лечения бронхиальной астмы – высокогорная климатотерапия внутренних болезней. Бишкек, 1991; с. 90-3 [Iakushenko MI. Features of adaptation of children to the mountain climate and the effectiveness of mountain climatic treatment of bronchial asthma – high mountain climatotherapy of internal diseases. Bishkek, 1991; p. 90-3 (in Russian)].
  6. Колчинская А.З., Цыганова Т.Н., Остапенко Л.А. Нормобарическая интервальная гипоксическая тренировка в медицине и спорте. М.: Медицина, 2003 [Kolchinskaia AZ, Tsyganova TN, Ostapenko LA. Normobaric interval hypoxic training in medicine and sports. Moscow: Meditsina, 2003 (in Russian)].
  7. Гридин Л.А. Современные представления о физиологических и лечебно-профилактических эффектах действия гипоксии и гиперкапнии. Медицина. 2016;3:45-68 [Gridin LA. Sovremennye predstavleniia o fiziologicheskikh i lechebno-profilakticheskikh effektakh deistviia gipoksii i giperkapnii. Meditsina. 2016;3:45-68 (in Russian)].
  8. Serebrovskaya TV, Bakunovsky AN, Nesvitailova KV, Mankovska IN. Intermittent Hypoxia in Treatment of Bronchial Asthma in Childhood. London: Springer, 2012; р.135-43.
  9. Геппе Н.А., Даирова Р.А., Урбах В.А. Немедикаментозная реабилитация при бронхиальной астме у детей. Педиатрия. 1994;1:73-8 [Geppe NA, Dairova RA, Urbah VA. Nemedikamentoznaia reabilitatsiia pri bronkhial'noi astme u deteii. Pediatriia. 1994;1:73-8 (in Russian)].
  10. Navarrete-Opazo A, Mitchell GS. Therapeutic potential of intermittent hypoxia: a matter of dose. Am J Physiol Regul Integr Comp Physiol. 2014;307(10):R1181-97.
  11. Shatylo VB, Serebrovska TV, Gavalko AV, et al. Acute hypoxic test in patients with prediabetes. High Alt Med Biol. 2016;17:101-7.
  12. Глазачев О.С., Геппе Н.А., Тимофеев Ю.С., и др. Индикаторы индивидуальной устойчивости к гипоксии – путь оптимизации применения гипоксических тренировок у детей. Рос. вестн. перинатол. и педиатр. 2020;65:(4):78-84 [Glazachev OS, Geppe NA, Timofeev YuS, et al. Indikatory individualnoi ustoichivosti k gipoksii – put optimizatsii primeneniia gipoksicheskikh trenirovok u detei. Ros. vestn. perinatol. i pediatr. 2020;65:(4):78-84 (in Russian)].
  13. Особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (Covid-19) у детей. Методические рекомендации. Версия 2 (3.07.2020); Минздрав России. Режим доступа: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_%D0%B4%D0%B5%D1%82%D0%B8_COVID-19_v2.pdf. Ссылка активна на 06.06.2021 [Features of clinical manifestations and treatment of a disease caused by a new coronavirus infection (Covid-19) in children. Methodical recommendations. Version 2 (07/03/2020); Ministry of Health of Russia. Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_deti_COVID-19_v2.pdf. Accessed: 06.06.2021 (in Russian)].
  14. Wang JY, Pawankar R, Tsai HJ, et al. COVID-19 and asthma, the good or the bad? Allergy. 2021;76(2):565-7. doi: 10.1111/all.14480
  15. Геппе Н.А., Колосова Н.Г., Шахназарова М.Д., и др. Инфекция COVID-19 у детей с бронхиальной астмой: клинические проявления, варианты течения, подходы к терапии. Иммунология. 2021;42(1):49-59 [Geppe NA, Kolosova NG, Shakhnazarova MD, et al. Infektsiia COVID-19 u detei s bronkhial’noi astmoi: klinicheskie proiavleniia, varianty techeniia, podkhody k terapii. Immunologiia. 2021;42(1):49-59 (in Russian)].
  16. Williams РCM, Howard-Jones A-R, Hsu P, et al. SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings. Pathology. 2020;52(7):801-8. doi: 10.1016/j.pathol.2020.08.001
  17. Фурман Е.Г. Коронавирусная инфекция COVID-19 и дети. Педиатрия. Журнал им. Г.Н. Сперанского. 2020;99(3):245-51 [Furman EG. Koronavirusnaia infektsiia COVID-19 i deti. Pediatriia. Zhurnal im. G.N. Speranskogo. 2020;99(3):245-51 (in Russian)].
  18. Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203-6.
  19. Denina M, Pruccoli G, Scolfaro C, et al. Sequelae of COVID-19 in Hospitalized Children: A 4-Months Follow-Up. Pediatr Infect Dis J. 2020;39(12):e458-e459. doi: 10.1097/INF.0000000000002937
  20. Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика». 5-е изд. М.: Оригинал-макет, 2017 [National program “Bronchial asthma in children. Treatment strategy and prevention”. 5th ed. Moscow: Original-maket, 2017 (in Russian)].

Statistics

Views

Abstract: 91

Dimensions

Article Metrics

Metrics Loading ...

PlumX

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies